Advent Venture Partners appoints new bio-tech executive-in-residence(2)

Advent Venture Partners has hired Dr Richard Mason, a former senior vice-president at Cambridge Antibody Technology, as its executive-in-residence.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this